Announcements Trials
Browse Landscape

Phase

Phase 2 43Phase 3 16Phase 1/2 13Phase 1 9Phase NA 5Phase 4 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1

Conditions

Colorectal Neoplasms 2Physician Education 1Gastrointestinal Stromal Tumors 1Colorectal Cancer Metastatic 1

Interventions

Capecitabine 13Fluorouracil 11Oxaliplatin 10Bevacizumab 9Leucovorin 6Irinotecan 6HMPL-013 4Folfox protocol 4Cetuximab 4ferric carboxymaltose 3regorafenib 2gadolinium ethoxybenzyl DTPA 2gadobenic acid 2Triamcinolone 2Standard of Care 2Sodium Chloride 2Radiofrequency Ablation 2Pirinitramide 2Morphine 2Esomeprazole 2Analgesia, Epidural 2zidovudine 5'-monophosphate-mannose-albumin conjugate 1sodium phosphate 1raltitrexed 1polyethylene glycol 3350 1iron isomaltoside 1000 1galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20 1gadoteridol 1gadoterate meglumine 1gadodiamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Colorectal Neoplasms × regorafenib × Clear all
NCT03564938 2024-12-03

Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).

Bayer

Phase 4 Completed
100 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02800330 2018-08-02

REGORA

Erasmus Medical Center

Phase 4 Completed
31 enrolled
GastrointestinalSarcoma

Colorectal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡